SOLICITATION NOTICE
66 -- Notice of Intent to Sole Source
- Notice Date
- 6/16/2017
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-1184957
- Archive Date
- 7/15/2017
- Point of Contact
- Christine L. Russman, Phone: 3017967841
- E-Mail Address
-
Christine.Russman@fda.hhs.gov
(Christine.Russman@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Notice of Intent to Sole Source purchase of custom cytokine analysis plates for use the existing MSD Sector Imager 2400, Model 1250. Document Type: Notice of Intent to Sole Source Solicitation Number: FDA - Sole Source - 1184957 Posted Date: 16 June 2017 Response Date: 30 June 2017 NAICS Code: 334516, Analytical Laboratory Instrument Manufacturing, Small Size Standard 1,000 Employees. The Food and Drug Administration intends to make a sole source award for Multi-spot custom cytokine plates in the amount of $28,857.50. The award will be made to: Meso Scale Discovery 1601 Research Boulevard Rockville, MD 20850 In accordance with FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The Division of Applied Regulatory Science (DARS) OCP/OTS/CDER is testing various small and large molecule drug products to determine if cytokine release syndrome can be predicted using a ‘humanized' mouse animal model. This assay requires that we evaluate up to 15 cytokines simultaneously in 96-well format using very small sample volumes. We have completed method discovery and development on the Meso Scale Discovery (MSD) multiplex platform which uses a proprietary MSD analyzer. In order to ensure comparability and validity of data, we need to continue using the MSD platform. This requisition seeks to have MSD create custom plates to assay the cytokines we have validated in a single sample well which are GM-CSF, IFN-γ, IL-2, IL-6, IL-8, IL-10, IL-12/IL-23/p40, IL-13, IL-17A and TNF-α. The program requires custom cytokine analysis plates to use with their existing MSD Sector Imager 2400, Model 1250. The custom plate is required because of the extremely small sample size and requires the limit of detection offered by MSD system products. All validation and development work has already been completed using the MSD imager. This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement within five (5) days after the publication of this synopsis which shall be considered by the agency. Responses received after 5 days or without the required information may not be considered. For information concerning this acquisition contact: Christine Russman Contract Specialist Christine.Russman@fda.hhs.gov (301) 796 - 7841. A determination by the Government not to compete as a result of information received is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-1184957/listing.html)
- Place of Performance
- Address: Food and Drug Administration, White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20903, United States
- Zip Code: 20903
- Zip Code: 20903
- Record
- SN04548071-W 20170618/170616235044-527f01863cfb6220f15401ac702ea982 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |